In contrast, Kras activation in combination with heterozygous PTEN deletion induced mixed carcinomas of liver (both iCCA and HCC), whereas Kras activation alone did not induce biliary tract neoplasm [188]. The gene discussed is KRAS; the disease is biliary tract neoplasm.